Baucus and Grassley say the FDA suppresses scientific dissent

Share this article:
Sens. Max Baucus (D-MT) and Chuck Grassley (R-IA) say the FDA continues to suppress scientific dissent and punish agency staff who raise safety issues. In a letter to the FDA commissioner, the senators say an unnamed senior FDA official has been sidelined after voicing concerns about the safety of GlaxoSmithKline's diabetes drug Avandia.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.